ARROYO HIDALGO, SERGIO,RIZO MARTINEZ, JOSÉ MIGUEL,GOMEZ CALVO, ANTONIA,SANZ MENENDEZ, NURIA
申请号：
ES201201233
公开号：
ES2468665A1
申请日:
2012.12.14
申请国别(地区):
ES
年份:
2014
代理人:
摘要：
Pharmaceutical composition of chondroitin sulfate and celocexib. The present invention relates to a pharmaceutical composition of chondroitin sulfate and celecoxib. In particular, it relates to a composition for oral administration in which the weight ratio between chondroitin sulfate and celecoxib is between 1.5: 1 and 2.5: 1, a ratio which is particularly effective for the treatment of damaged cartilages. In patients with osteoarthritis. It also refers to a pharmaceutical unit dosage form, in particular a tablet and a capsule, comprising a therapeutically effective amount of said composition. It also relates to the use of said composition for the preparation of a medicament for the treatment of osteoarthritis. (Machine-translation by Google Translate, not legally binding)Composici�n farmac�utica de sulfato de condroitina y celocexib.#La presente invenci�n se refiere a una composici�n farmac�utica de sulfato de condroitina y celecoxib. En particular, se refiere a una composici�n para administraci�n oral en la que la relaci�n en peso entre sulfato de condroitina y celecoxib est� comprendida entre 1,5:1 y 2,5:1, proporci�n que resulta particularmente eficaz para el tratamiento de cart�lagos da�ados en pacientes con artrosis. Tambi�n se refiere a una forma farmac�utica de dosificaci�n unitaria, en particular un comprimido y una c�psula, que comprende una cantidad terap�uticamente efectiva de dicha composici�n. Tambi�n se refiere al uso de dicha composici�n para la preparaci�n de un medicamento para el tratamiento de la artrosis.
